- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1934
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
New Oral Drugs for Migraine ; volume:36 ; number:9 ; day:29 ; month:8 ; year:2022 ; pages:933-949 ; date:9.2022
CNS drugs ; 36, Heft 9 (29.8.2022), 933-949, 9.2022
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40263-022-00948-8
- URN
-
urn:nbn:de:101:1-2022120221322775047270
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Karsan, Nazia
- Goadsby, Peter J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
New drugs for migraine
Migraine drugs
Therapeutic novelties in migraine: new drugs, new hope?
Correction to: Therapeutic novelties in migraine: new drugs, new hope?
The history and rationale of the development of new drugs for migraine treatment
Optimising migraine treatment: from drug-drug interactions to personalized medicine
Proteome-wide Mendelian randomization identified potential drug targets for migraine
Novel drug-loaded paper tablets for improved oral drug delivery
Are the current IHS guidelines for migraine drug trials being followed?
New directions in migraine
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate
Drug–Drug Interactions with Direct Oral Anticoagulants
New drugs for migraine
Migraine drugs
Therapeutic novelties in migraine: new drugs, new hope?
Correction to: Therapeutic novelties in migraine: new drugs, new hope?
The history and rationale of the development of new drugs for migraine treatment
Optimising migraine treatment: from drug-drug interactions to personalized medicine
Proteome-wide Mendelian randomization identified potential drug targets for migraine
Novel drug-loaded paper tablets for improved oral drug delivery
Are the current IHS guidelines for migraine drug trials being followed?
New directions in migraine
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate
Drug–Drug Interactions with Direct Oral Anticoagulants
New drugs for migraine
Migraine drugs
Therapeutic novelties in migraine: new drugs, new hope?
Correction to: Therapeutic novelties in migraine: new drugs, new hope?
The history and rationale of the development of new drugs for migraine treatment
Optimising migraine treatment: from drug-drug interactions to personalized medicine
Proteome-wide Mendelian randomization identified potential drug targets for migraine
Novel drug-loaded paper tablets for improved oral drug delivery
Are the current IHS guidelines for migraine drug trials being followed?
New directions in migraine
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate